Advertisement

ACR 2020

ACR 2020

Meeting Coverage

ACR Convergence 2020 – eBook

Convergence Psoriasis Report v1.indd   Featuring Phase III PALACE 4: Apremilast Sustains PsA Control after 1-Year Phase 3 Trials Find Guselkumab Significantly Reduces Fatigue with PsA Effects of Ixekizumab on Symptoms of...